Medtronic PLC at Morgan Stanley Healthcare Conference Transcript
(technical difficulty)
here as we progress through the morning. My name is David Lewis, medical device analyst at Morgan Stanley. It's my pleasure to have with us here the CEO of Medtronic, Omar Ishrak.
Questions & Answers
And I thought, Omar, just given the recent news, we kind of start off with probably the most important question. Obviously, you've announced your transition and retirement. So I guess the best question will be -- you've also named a successor. Why was Geoff Martha -- as you know, Geoff Martha ran a division for Medtronic, the RTG business. Why is Geoff the right choice to continue on as -- and run Medtronic?
Yes. Well, first, let me give a little perspective on the process and some of the philosophies. This was a process that the Board went through last 4, 5 years with increasing intensity as time went by. I knew
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |